Previous 10 | Next 10 |
ATLANTA, April 01, 2024 (GLOBE NEWSWIRE) -- Holzer & Holzer, LLC is investigating whether Doximity, Inc. (“Doximity” or the “Company”) (NYSE: DOCS) complied with federal securities laws. On April 1, 2024, Jehoshaphat Research published a report alleging, among ...
2024-04-01 11:15:48 ET More on Doximity Doximity: Rating Upgrade To Buy As Outlook Turns Positive Doximity, Inc. (DOCS) Q3 2024 Earnings Call Transcript Doximity: Downside Is Contained, While Upside Depends On Management's Game Plan Doximity beats top-line an...
2024-03-09 04:50:41 ET Summary Health Catalyst reported strong Q4 results, meeting guidance and showing growth in technology and professional services revenue. The drop in HCAT's share price presents a buying opportunity, as the company's growth initiatives, such as its TEMS offer...
2024-03-01 07:32:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-02-23 00:10:00 ET Summary Over the fourth quarter of 2023, the Polen Global SMID Company Growth Composite Portfolio (the “Portfolio”) returned 10.04% gross and 9.92 % net of fees, respectively, versus the 11.63% return of the MSCI ACWI SMID Capitalization Index (the...
2024-02-21 08:30:00 ET Investing in a bull market isn't always as straightforward as it seems. It's easy to find stocks that are doing well during a bull run, but some end up rising too much, too fast, leading to significant corrections once things turn sour. Finding stocks that aren't ...
2024-02-21 06:15:00 ET Most stocks suffering a 70% decline in share price tend not to qualify as anything close to a cash cow capable of generating immense free cash flow (FCF). But Doximity (NYSE: DOCS) , with its digital platform for healthcare professionals, is the exception to t...
2024-02-20 22:21:23 ET Summary Doximity's share price has rallied, prompting an upgrade to a buy rating based on positive 3Q24 performance and growth outlook. Revenue growth of 17.4% in 3Q24, strong operating metrics, and positive feedback on the new client portal support a positi...
2024-02-19 16:08:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-02-08 20:50:03 ET Doximity, Inc. (DOCS) Q3 2024 Earnings Conference Call February 08, 2024, 05:00 PM ET Company Participants Perry Gold - VP of IR Jeffrey Tangney - Co-Founder and CEO Anna Bryson - CFO Nate Gross - Co-Founder and CSO Conference Cal...
News, Short Squeeze, Breakout and More Instantly...
Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (“KSF”), announces that KSF has commenced an investigation into Doximity, Inc. (NYSE: DOCS). On August 8, 2023, the Company disclosed disappointing guidance ...
Doximity, Inc. (NYSE:DOCS), the leading digital platform for U.S. medical professionals, today announced it will report financial results for its fiscal first quarter ended June 30, 2024 after market close on August 8, 2024. Doximity will host a conference call and webcast at 2:00 p.m. PT (5:00 p...
2024-07-10 22:40:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...